Elite in Cholangiocarcinoma (Bile Duct Cancer)
Check Dr. Lipika C. Goyal's experience treating your condition:
About Dr. Lipika C. Goyal

Lipika Goyal is a Hematologist Oncology expert in Boston, Massachusetts. Goyal has been practicing medicine for over 16 years and is rated as an Elite expert by MediFind in the treatment of Cholangiocarcinoma (Bile Duct Cancer). She is also highly rated in 16 other conditions, according to our data. Her top areas of expertise are Cholangiocarcinoma (Bile Duct Cancer), Liver Cancer, Fibrolamellar Carcinoma, Tissue Biopsy, and Liver Embolization. She is licensed to treat patients in Massachusetts. Goyal is currently accepting new patients.

Her clinical research consists of co-authoring 101 peer reviewed articles and participating in 8 clinical trials in the past 15 years. In particular, she has co-authored 45 articles and participated in 6 clinical trials in the study of Cholangiocarcinoma (Bile Duct Cancer).


MediFind strives to display the most accurate insurance information for every doctor. If you do not see your insurance listed for Dr. Lipika C. Goyal it is best to call her office and ask if your insurance is accepted.

Accepts Medicare

Call to see if your plan is accepted.
55 Fruit St, Boston, MA 02114
Background & Education
Graduate Institution
Harvard Medical School, 2007
Hematology Oncology
Internal Medicine in MA
Hospital Affiliations
Massachusetts General Hospital
North Shore Medical Center - Salem Hospital
Languages Spoken
Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Doctors who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

8 Clinical Trials

A Phase II Study of Olaparib in Patients With Advanced Biliary Tract Cancer With Aberrant DNA Repair Gene Mutations
A Single Arm Phase II Study of the Combination of DKN-01 and Nivolumab in Previously Treated Patients With Advanced Biliary Tract Cancer (BTC)
Phase II Trial of Sorafenib in Combination With Modified FOLFOX in Patients With Advanced Hepatocellular Carcinoma
A Randomized Phase 2 Study of Atezolizumab in Combination With Cobimetinib Versus Atezolizumab Monotherapy in Participants With Unresectable Cholangiocarcinoma
A Phase 1, First-in-Human, Open-Label, Dose Escalation Study of MGD013, A Bispecific DART® Protein Binding PD-1 and LAG-3 in Patients With Unresectable or Metastatic Neoplasms
View 6 Less Clinical Trials -

Save this doctor for later
Sign Up
Looking for the best doctor for you?
Start Here
Is this your doctor?
Find a second opinion
Not sure about your diagnosis?
Check Your Symptoms
Learn about our expert tiers
Learn more
Similar Doctors